26PD - An innovative technology for in vivo isolation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients and immunofluorescent detec...
|Date||27 March 2014|
|Session||Poster Discussion 1|
|Topics|| Non-Small-Cell Lung Cancer, Metastatic
|Citation||Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131|
B. Dlugaszewska1, L. Gasiorowski2, S. Herold1, B. Nowack3, G. Dworacki4, K. Luecke5, W. Dyszkiewicz2
Circulating tumor cells (CTCs) in lung cancer patients can provide additional information on patient prognosis and treatment efficacy. Currently, CTCs are isolated in vitro from limited volumes of patient blood samples. To overcome this limitation, an innovative device, Detektor CANCER01 (DC01), was used to isolate CTCs in vivo, directly from the bloodstream of lung cancer patients.